Oral GLP-1 breakthrough in metabolic disease treatment
14th March 2025
Discover how Poolbeg Pharma is revolutionizing the delivery of GLP-1R agonists to combat metabolic diseases like diabetes and obesity on a global scale.
Discover how Poolbeg Pharma is revolutionizing the delivery of GLP-1R agonists to combat metabolic diseases like diabetes and obesity on a global scale.
Participate in paid clinical trials with FluCamp to contribute to medical breakthroughs and earn financial compensation. Learn how to get involved in these important studies.
Discover the groundbreaking new prostate cancer detection test by EDX Medical Group, set to revolutionize early diagnosis for improved treatment outcomes.
Poolbeg Pharma is gearing up for BioTrinity 2025. Don’t miss this premier life sciences event!
Japan is considering human challenge trials to speed up vaccine development. This bold move could position the country at the forefront of medical research.
Discover the revolutionary AI-powered prostate cancer screening test developed in Cambridge. EDX Medical Group is leading the way in personalised treatment solutions.
EDX Medical Group plc founder, Professor Chris Evans, discusses the company’s new super-test for prostate cancer and its innovative approach to diagnostics.
Discover how artificial intelligence is revolutionizing the drug development process, reducing costs, accelerating timelines, and improving patient recruitment.
One Health Group is embarking on ambitious growth plans with a multimillion-pound fundraising initiative and move to London’s AIM market. Join the journey!
Discover EDX Medical’s revolutionary non-invasive prostate cancer diagnostic, utilising AI and multi-omics technology for unparalleled accuracy and personalized treatment strategies.
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
